EQS-Adhoc: Marinomed Biotech AG applies for court restructuring proceedings without self-administration
   EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of
   Company
   Marinomed Biotech AG applies for court restructuring proceedings without
   self-administration

   13-Aug-2024 / 23:04 CET/CEST
   Disclosure of an inside information acc. to Article 17 MAR of the
   Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS
   Group AG.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   Korneuburg, Austria, 13. August 2024 – Marinomed Biotech AG (VSE:MARI)
   announces to apply for the initiation of court restructuring proceedings.
   The aim is to carry out restructuring proceedings without
   self-administration.

   As a result of the inability to raise funds required at short notice to
   secure the Company’s liquidity, insolvency is imminent. As announced,
   revenue expectations for the 2024 financial year could not yet be realized
   as planned. Aim of the restructuring proceedings without
   self-administration is to sustainably secure the Company’s financial
   stability according to a restructuring plan. For this purpose, besides
   restructuring measures, proceeds including from the realization of
   strategic options regarding the Carragelose business are intended to be
   used. The publication of the half-year financial statements planned for
   August 20, 2024, has been postponed.

   +++ End of ad-hoc announcement +++
    

   End of Inside Information

   ══════════════════════════════════════════════════════════════════════════

   13-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com

   ══════════════════════════════════════════════════════════════════════════

   Language:    English
   Company:     Marinomed Biotech AG
                Hovengasse 25
                2100 Korneuburg
                Austria
   Phone:       +43 2262 90300
   E-mail:      office@marinomed.com
   Internet:    www.marinomed.com
   ISIN:        ATMARINOMED6
   WKN:         A2N9MM
   Listed:      Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt,
                Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange
                (Official Market)
   EQS News ID: 1967439


    
   End of Announcement EQS News Service


   1967439  13-Aug-2024 CET/CEST

live draw hongkong

togel hongkong

togel hk

togel hongkong

By adminn